We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+7.56%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$310B
AUM Growth
+$8.85B
Cap. Flow
-$12.9B
Cap. Flow %
-4.15%
Top 10 Hldgs %
14.55%
Holding
10,459
New
1,343
Increased
3,599
Reduced
4,168
Closed
927

Sector Composition

Rank Sector Weight
1 Technology 11.88%
2 Financials 7.38%
3 Consumer Discretionary 6.3%
4 Healthcare 6.09%
5 Communication Services 4.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRDX
8026
GridAI Technologies Corp
GRDX
$21.2M
0
MTVA
8027
MetaVia Inc
MTVA
$7.8M
$10K ﹤0.01%
1
AE
8028
DELISTED
Adams Resources & Energy Inc
AE
$10K ﹤0.01%
373
-1,260
-77% -$34.7K
VCNX
8029
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$10K ﹤0.01%
18
-119
-87% -$62.9K
PRMW
8030
DELISTED
Primo Water Corporation
PRMW
$10K ﹤0.01%
610
-42,956
-99% -$726K
MTBL
8031
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$10K ﹤0.01%
8,680
-7,320
-46% -$7.53K
CYT
8032
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$10K ﹤0.01%
+450
New +$8.43K
CSTA
8033
DELISTED
Constellation Acquisition Corp I
CSTA
$10K ﹤0.01%
+972
New +$9.53K
IMPL
8034
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$10K ﹤0.01%
+1,170
New +$14K
LHC.U
8035
DELISTED
Leo Holdings Corp. II Units, each consisting of one Class A ordinary share and one-quarter of one redeemable warrant
LHC.U
$10K ﹤0.01%
+968
New +$9.68K
KBNTW
8036
DELISTED
Kubient, Inc. Warrant
KBNTW
$10K ﹤0.01%
4,634
+1,476
+47% +$3.25K
AEY
8037
DELISTED
ADDvantage Technologies Group
AEY
$10K ﹤0.01%
+393
New +$9.24K
LTRPB
8038
DELISTED
Liberty TripAdvisor Holdings, Inc. Series B
LTRPB
$10K ﹤0.01%
+309
New +$11.1K
CCV
8039
DELISTED
Churchill Capital Corp V
CCV
$10K ﹤0.01%
956
-897
-48% -$8.98K
GFX
8040
DELISTED
Golden Falcon Acquisition Corp.
GFX
$10K ﹤0.01%
1,000
-3,928
-80% -$38.3K
NOVN
8041
DELISTED
Novan, Inc. Common Stock
NOVN
$10K ﹤0.01%
1,025
+1,000
+4,000% +$11.8K
ATTO
8042
DELISTED
Atento S.A.
ATTO
$10K ﹤0.01%
398
ERESU
8043
DELISTED
East Resources Acquisition Company Unit
ERESU
$10K ﹤0.01%
1,010
-1,182
-54% -$12K
FNCH
8044
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$10K ﹤0.01%
+23
New +$9.96K
GRCY
8045
DELISTED
Greencity Acquisition Corporation Ordinary Shares
GRCY
$10K ﹤0.01%
980
-1,000
-51% -$10.1K
RKTA.U
8046
DELISTED
Rocket Internet Growth Opportunities Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
RKTA.U
$10K ﹤0.01%
1,018
-22
-2% -$221
GXIIU
8047
DELISTED
GX Acquisition Corp. II Unit
GXIIU
$10K ﹤0.01%
+1,015
New +$10.1K
NEE.PRP
8048
DELISTED
NextEra Energy, Inc. 5.279% Corporate Units
NEE.PRP
$10K ﹤0.01%
200
CTAQ
8049
DELISTED
Carney Technology Acquisition Corp. II Class A Common Stock
CTAQ
$10K ﹤0.01%
+1,062
New +$10.4K
DHBC
8050
DELISTED
DHB Capital Corp. Class A common stock
DHBC
$10K ﹤0.01%
+975
New +$9.49K

Similar funds

UBS Group's Q2 2021 Portfolio in Review

As of Q2 2021, UBS Group held 10,459 positions worth $310B, up 2.9% from $301B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group withdrew a net $12.9B in Q2 2021, closing 927 positions and reducing 4,168 holdings. Its most notable exit was INPHI CORPORATION, an estimated $121M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, UBS Group opened a new position in Dimensional US Core Equity 2 ETF worth $42.4M.

  • UBS Group's largest Q2 2021 buy was Dimensional US Core Equity 2 ETF: 1,571,036 shares worth $42.4M.
  • UBS Group added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, an estimated $1.02B increase.
  • UBS Group's biggest Q2 2021 reduction was Alibaba, cutting an estimated $2.65B.
  • UBS Group fully exited INPHI CORPORATION in Q2 2021, selling an estimated $121M.
  • UBS Group's ten largest holdings make up 15% of its $310B portfolio in Q2 2021.
  • UBS Group opened 1,343 new positions and closed 927 in Q2 2021.
  • UBS Group's portfolio value rose 2.9% quarter-over-quarter to $310B.

Based on UBS Group's 13F filing for Q2 2021, filed 13 Aug 2021.